President Donald Trump will direct his top health officials to conduct a systematic review of the childhood vaccinations ...

Previously, Galmed announced the grant of new use patent for a combination of Aramchol and Madrigal Pharmaceuticals' Rezdiffra (Resmetirom) for MASH. The new patent extends Aramchol's patent ...

Formycon AG (FSE: FYB, Prime Standard) and MS Pharma jointly announce that they have entered into an exclusive licensing and ...

This peer-reviewed publication marks an important milestone following initial release of study information in August 2024 (see "Vaderis Announces Positive Clinical Proof-of-Concept Trial in HHT"). The ...

Advisors to the Centers for Disease Control and Prevention (CDC) voted 8-3 Friday to recommend that a mother without ...

Generative Artificial Intelligence or GenAI has been a useful tool for people to create new content, such as text, images, ...

Asana, Inc. (NYSE:ASAN) Q3 2026 Earnings Call Transcript December 2, 2025 Asana, Inc. misses on earnings expectations.

Asana, Inc. ( ASAN) Q3 2026 Earnings Call December 2, 2025 4:30 PM EST Thank you for standing by, and welcome to Asana's Third Quarter Fiscal Year 2026 Earnings Conference Call. [Operator Instructions ...

Emerald Clinical Trials, a leading global clinical research organization (CRO), today announced the appointment of Luke Gill, ...

Onctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces it has dosed the first patient in its Phase I/II clinical trial evaluating ...

The report offers key market opportunities in PTSD clinical trials by providing insights into global trial distribution, enrollment trends, and prominent drugs. It aids in identifying strategic ...

CNW/ -- (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient ...